Browsing Tag
biosimilars
17 posts
Dr. Reddy’s company profile: Respiratory, generics, and global drug pipeline in 2025
Explore Dr. Reddy’s FY25 financials, drug pipeline, and global expansion strategy—see why it’s gaining attention in pharma investment circles.
Bio-Thera Solutions and Tabuk Pharmaceuticals partner to bring BAT2206 to Saudi Arabia
Bio-Thera Solutions Inc., a Chinese biopharmaceutical company, has announced a strategic partnership with Tabuk Pharmaceutical Manufacturing Company, a…
Dr. Reddy’s Laboratories secures key European endorsement for Rituximab biosimilar
In a significant development for the pharmaceutical industry, Dr. Reddy’s Laboratories Ltd. has received a positive opinion from…
Lupin enters Brazilian oncology biosimilars market with Biomm deal for Pegfilgrastim
Lupin partners with Biomm SA to bring biosimilar Pegfilgrastim to Brazil, expanding oncology supportive care access and entering Latin America’s biologics market.
Samsung Bioepis partners with C-Bridge Capital to expand biosimilar portfolio in China
Samsung Bioepis, a South Korean leader in biopharmaceuticals, has struck a deal with private equity firm C-Bridge Capital…
Mylan launches Hulio, a biosimilar to Humira, across major European markets
Mylan has officially launched Hulio, its biosimilar to AbbVie’s Humira (adalimumab), across major European markets. This launch follows…
Boehringer Ingelheim’s Cyltezo achieves clinical equivalence to Humira in Phase 3 psoriasis trial
German pharmaceutical giant Boehringer Ingelheim has announced a significant milestone in the treatment of moderate-to-severe chronic plaque psoriasis.…